DMAC vs MTB · $157.4M cap vs P/E 12, $30.99B cap
DiaMedica Therapeutics Inc (DMAC) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
DMAC does not have a complete income-statement cache yet.
MTB does not have a complete income-statement cache yet.
DMAC currently screens at market cap $157.4M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the DMAC and MTB stock pages for the full models.
Not investment advice.